Booking Holdings Inc. Stock Rises Monday, Outperforms Market

Tempest Therapeutics Inc

Change company Symbol lookup

Select an option...

TPST Tempest Therapeutics Inc

PETV PetVivo Holdings Inc

KMI Kinder Morgan Inc

NXPL NextPlat Corp

D Dominion Energy Inc

CVS CVS Health Corp

CVI CVR Energy Inc

CTRE CareTrust REIT Inc

CSWC Capital Southwest Corp

CSCO Cisco Systems Inc

Health Care : Biotechnology |

Company profile

Tempest Therapeutics, Inc. (Tempest) is a clinical-stage oncology company. The Company is focused on developing small molecules that combine both tumor-targeted and immune-mediated mechanisms with the potential to treat a range of tumors. The Company’s two clinical programs include TPST-1120 and TPST-1495. TPST-1120 is a selective antagonist of peroxisome proliferator-activated receptor alpha (PPARa). TPST-1120 is in Phase I and II trials in solid tumors, including a global randomized Phase Ib/II trial in combination with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma (HCC). Its second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, and is in Phase I monotherapy and combination trials in solid tumors.

Booking Holdings Inc. Stock Rises Monday, Outperforms Market

4:41 pm ET March 27, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Booking Holdings Inc. (BKNG) inched 0.36% higher to $2,508.31 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.16% to 3,977.53 and the Dow Jones Industrial Average rising 0.60% to 32,432.08. The stock's rise snapped a three-day losing streak. Booking Holdings Inc. closed $121.69 short of its 52-week high ($2,630.00), which the company reached on March 7th.

Trading volume (246,227) remained 95,479 below its 50-day average volume of 341,706.

Data source: Dow Jones Market Data, FactSet. Data compiled March 27, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 27, 2023 16:41 ET (20:41 GMT)